Elizabeth A. Barrett - 30 Jul 2021 Form 4 Insider Report for Allogene Therapeutics, Inc. (ALLO)

Role
Director
Signature
/s/ Veer Bhavnagri, Attorney-in-Fact
Issuer symbol
ALLO
Transactions as of
30 Jul 2021
Net transactions value
$0
Form type
4
Filing time
03 Aug 2021, 17:32:38 UTC
Previous filing
21 May 2021
Next filing
07 Jan 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALLO Stock Option (Right to Buy) Award $0 +63,385 $0.000000 63,385 30 Jul 2021 Common Stock 63,385 $21.95 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the stock option shall vest in a series of 36 successive equal monthly installments measured from the date of grant.